These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 8828766

  • 1. Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment.
    Fukutomi M, Kobayashi S, Niwaya K, Hamada Y, Kitamura S.
    Artif Organs; 1996 Jul; 20(7):767-76. PubMed ID: 8828766
    [Abstract] [Full Text] [Related]

  • 2. Biocompatibility of heparin-coated membrane oxygenator during cardiopulmonary bypass.
    Hatori N, Yoshizu H, Haga Y, Kusama Y, Takeshima S, Segawa D, Tanaka S.
    Artif Organs; 1994 Dec; 18(12):904-10. PubMed ID: 7887827
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices.
    Baksaas ST, Videm V, Pedersen T, Karlsen H, Mollnes TE, Brosstad F, Svennevig JL.
    Perfusion; 1999 Mar; 14(2):119-27. PubMed ID: 10338323
    [Abstract] [Full Text] [Related]

  • 5. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility.
    Gu YJ, Boonstra PW, Rijnsburger AA, Haan J, van Oeveren W.
    Ann Thorac Surg; 1998 May; 65(5):1342-7. PubMed ID: 9594864
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Protective effect of heparin-coated circuits on the platelets during cardiopulmonary bypass.
    Zhang K, Hu Z, Yang Y, Huang R, Fan H, Sun Z.
    J Huazhong Univ Sci Technolog Med Sci; 2003 May; 23(4):403-6. PubMed ID: 15015647
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative study of biocompatibility between the open circuit and closed circuit in cardiopulmonary bypass.
    Nishida H, Aomi S, Tomizawa Y, Endo M, Koyanagi H, Nojiri C, Oshiyama H, Kido T, Yokoyama K.
    Artif Organs; 1999 Jun; 23(6):547-51. PubMed ID: 10392283
    [Abstract] [Full Text] [Related]

  • 10. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
    Muehrcke DD, McCarthy PM, Kottke-Marchant K, Harasaki H, Pierre-Yared J, Borsh JA, Ogella DA, Cosgrove DM.
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
    [Abstract] [Full Text] [Related]

  • 11. Biocompatibility of heparin-coated circuits used in cardiopulmonary bypass.
    Pekna M, Borowiec J, Fagerhol MK, Venge P, Thelin S.
    Scand J Thorac Cardiovasc Surg; 1994 Aug; 28(1):5-11. PubMed ID: 7939508
    [Abstract] [Full Text] [Related]

  • 12. Clinical evaluation of a silicone coated hollow fiber oxygenator.
    Shimono T, Shomura Y, Tani K, Shimamoto A, Hioki I, Tokui T, Onoda K, Takao M, Shimpo H, Yada I.
    ASAIO J; 1997 Aug; 43(5):M735-9. PubMed ID: 9360143
    [Abstract] [Full Text] [Related]

  • 13. Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass.
    Cavarocchi NC, Schaff HV, Orszulak TA, Homburger HA, Schnell WA, Pluth JR.
    Surgery; 1985 Sep; 98(3):525-31. PubMed ID: 3875906
    [Abstract] [Full Text] [Related]

  • 14. Differences in blood activation related to roller/centrifugal pumps and heparin-coated/uncoated surfaces in a cardiopulmonary bypass model circuit.
    Moen O, Fosse E, Bråten J, Andersson C, Høgåsen K, Mollnes TE, Venge P, Kierulf P.
    Perfusion; 1996 Mar; 11(2):113-23. PubMed ID: 8740352
    [Abstract] [Full Text] [Related]

  • 15. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass.
    Gorman RC, Ziats N, Rao AK, Gikakis N, Sun L, Khan MM, Stenach N, Sapatnekar S, Chouhan V, Gorman JH, Niewiarowski S, Colman RW, Anderson JM, Edmunds LH.
    J Thorac Cardiovasc Surg; 1996 Jan; 111(1):1-11; discussion 11-2. PubMed ID: 8551753
    [Abstract] [Full Text] [Related]

  • 16. Effects of heparin coating of cardiopulmonary bypass circuits on in vitro oxygen free radical production during coronary bypass surgery.
    Bozdayi M, Borowiec J, Nilsson L, Venge P, Thelin S, Hansson HE.
    Artif Organs; 1996 Sep; 20(9):1008-16. PubMed ID: 8864022
    [Abstract] [Full Text] [Related]

  • 17. Clinical study of platelet function and coagulation/fibrinolysis with Duraflo II heparin coated cardiopulmonary bypass equipment.
    Nakajima T, Osawa S, Ogawa M, Sasaki T, Izumoto H, Yagi Y, Kawazoe K.
    ASAIO J; 1996 Sep; 42(4):301-5. PubMed ID: 8828788
    [Abstract] [Full Text] [Related]

  • 18. Comparison of a Duraflo II-coated cardiopulmonary bypass circuit and a trillium-coated oxygenator during open-heart surgery.
    Hoel TN, Videm V, Baksaas ST, Mollnes TE, Brosstad F, Svennevig JL.
    Perfusion; 2004 May; 19(3):177-84. PubMed ID: 15298426
    [Abstract] [Full Text] [Related]

  • 19. Complete heparin-coated cardiopulmonary bypass and low heparin dose reduce complement and granulocyte activation.
    Ovrum E, Fosse E, Mollnes TE, Am Holen E, Tangen G, Abdelnoor M, Ringdal MA, Oystese R, Venge P.
    Eur J Cardiothorac Surg; 1996 May; 10(1):54-60. PubMed ID: 8776186
    [Abstract] [Full Text] [Related]

  • 20. Heparin-coated circuits reduce the formation of TNF alpha during cardiopulmonary bypass.
    Yamada H, Kudoh I, Hirose Y, Toyoshima M, Abe H, Kurahashi K.
    Acta Anaesthesiol Scand; 1996 Mar; 40(3):311-7. PubMed ID: 8721461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.